CR6500A - Amidas aromaticas - Google Patents

Amidas aromaticas

Info

Publication number
CR6500A
CR6500A CR6500A CR6500A CR6500A CR 6500 A CR6500 A CR 6500A CR 6500 A CR6500 A CR 6500A CR 6500 A CR6500 A CR 6500A CR 6500 A CR6500 A CR 6500A
Authority
CR
Costa Rica
Prior art keywords
aromatic
amidas
heteroaromatic
seizures
schizophrenia
Prior art date
Application number
CR6500A
Other languages
English (en)
Inventor
Stephen Bryans Justin
Otoole John
Christopher Horwell David
Original Assignee
Warner Lambert Co
Abr Llc
Acumer Investigacion Desarrollo S L
Antonio Jose De Jesus De San Juan Bosco Echevarria Parres
Dystar Textilfarben Gmbh Y Co Deutschland Kg
Eco Flora S A
John Larry Sanders
Ranka Seema Ajay
Sanofi Aventis
Smithjkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co, Abr Llc, Acumer Investigacion Desarrollo S L, Antonio Jose De Jesus De San Juan Bosco Echevarria Parres, Dystar Textilfarben Gmbh Y Co Deutschland Kg, Eco Flora S A, John Larry Sanders, Ranka Seema Ajay, Sanofi Aventis, Smithjkline Beecham Corp filed Critical Warner Lambert Co
Publication of CR6500A publication Critical patent/CR6500A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/36—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C07C247/16—Compounds containing azido groups with azido groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Las Amidas aromáticas y heteroaromáticas de la fórmula I, donde R1, R2 y R3 pueden ser alquilo, X es alquileno y R4 es un grupo aromático o heteroaromático no sustituido o sustituido tal como naftilo o fluorenilo, son agentes útiles para el sistema nervioso central para tratar dolor, depresión, ansiedad, ataques y esquizofrenia
CR6500A 1999-05-10 2001-11-08 Amidas aromaticas CR6500A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13335999P 1999-05-10 1999-05-10

Publications (1)

Publication Number Publication Date
CR6500A true CR6500A (es) 2004-03-08

Family

ID=22458233

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6500A CR6500A (es) 1999-05-10 2001-11-08 Amidas aromaticas

Country Status (28)

Country Link
US (1) US6846953B1 (es)
EP (1) EP1178953B1 (es)
JP (1) JP2002544186A (es)
KR (1) KR20010111594A (es)
CN (1) CN1352631A (es)
AP (1) AP2001002321A0 (es)
AT (1) ATE255559T1 (es)
AU (1) AU4594900A (es)
BG (1) BG106072A (es)
BR (1) BR0010465A (es)
CA (1) CA2373173A1 (es)
CR (1) CR6500A (es)
CZ (1) CZ20013924A3 (es)
DE (1) DE60006954T2 (es)
DK (1) DK1178953T3 (es)
EA (1) EA200101058A1 (es)
ES (1) ES2208324T3 (es)
HU (1) HUP0201069A3 (es)
IL (1) IL146340A0 (es)
IS (1) IS6136A (es)
MA (1) MA26789A1 (es)
NO (1) NO20015412L (es)
OA (1) OA11941A (es)
PL (1) PL354356A1 (es)
PT (1) PT1178953E (es)
SK (1) SK16052001A3 (es)
TR (1) TR200103245T2 (es)
WO (1) WO2000068184A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006043171A2 (en) * 2004-10-23 2006-04-27 Warner-Lambert Company Llc Methods of using alpha2delta-1 selective compounds
WO2011026107A1 (en) 2009-08-31 2011-03-03 University Of Notre Dame Du Lac Phthalanilate compounds and methods of use

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB855770A (en) 1956-12-27 1960-12-07 American Cyanamid Co N-substituted anilides and their preparation
US3101339A (en) * 1958-10-30 1963-08-20 Boehringer Sohn Ingelheim Quaternary salts of normorphine and its acylated derivatives
US3016382A (en) 1958-12-15 1962-01-09 American Cyanamid Co N-substituted anilides and method of preparing the same
DE1232147B (de) 1961-04-13 1967-01-12 Bayer Ag Verfahren zur Herstellung von acylierten N-(Alkylaminoalkyl)-aminopyridinen
GB1232787A (es) 1967-08-08 1971-05-19
FR2073286A1 (en) 1969-12-23 1971-10-01 Robert Et Carriere Labo Substd anilines - with antirheumatic analgesic and antiinflammatory activity
US4203988A (en) 1975-11-12 1980-05-20 Merck & Co., Inc. Pyridinyl ureas and pharmaceutical use
US4180522A (en) 1976-12-02 1979-12-25 The Upjohn Company N-(2-Dimethylaminoalkyl)-3',4'-dichloroanilides
US4186208A (en) 1976-12-02 1980-01-29 The Upjohn Company Anti-depressant N-(3,4-dichlorophenyl)-N-dimethylaminoalkylene amides
JPS5520471A (en) 1978-08-01 1980-02-13 Kyowa Hakko Kogyo Co Ltd Hydrogen peroxide quantifying method
US4286106A (en) 1978-08-16 1981-08-25 The Upjohn Company N-[ω-(Dimethylamino)alkyl]-3',4'-dichloropropionanilides
US4293703A (en) 1979-01-18 1981-10-06 Merck & Co., Inc. Imidazole or imidazoline substituted ureas
US4241072A (en) 1979-01-18 1980-12-23 Merck & Co., Inc. Substituted ureas and processes for their preparation
EP0084292B1 (en) * 1981-12-14 1985-02-13 Sandoz Ag N,n-disubstituted alkenamides and phenylalkenamides, processes for their production and their use as pharmaceuticals
DE3406329A1 (de) 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone
US5654301A (en) 1985-02-15 1997-08-05 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
US4952584A (en) 1986-01-11 1990-08-28 Beecham Group P.L.C. 9H-pyrido[2,B-8]indole-3-carboxylic acid ester compounds having useful pharmaceutical activity
CA1292226C (en) 1986-01-16 1991-11-19 Terumi Hachiya Indenothiazole derivative and process for preparing the same
FR2618149B1 (fr) 1987-07-16 1989-09-22 Synthelabo Derives de n-aminoalkyl n-phenyl arylamides, leur preparation et leur application en therapeutique
US5474994A (en) 1992-05-26 1995-12-12 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
US5605896A (en) 1992-02-25 1997-02-25 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities
IT1254469B (it) 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US5372932A (en) 1992-12-22 1994-12-13 Eastman Kodak Company Analytical element and method for the determination of a specific binding ligand using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer
US5464788A (en) * 1994-03-24 1995-11-07 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
US5453533A (en) 1994-04-14 1995-09-26 The University Of Alabama At Birmingham Inhibitors of influenza virus neuraminidase and methods of making and using the same
US5880158A (en) * 1996-09-27 1999-03-09 Research Corporation Tech., Inc. Propionamide anticonvulsants
GB9707830D0 (en) * 1997-04-18 1997-06-04 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
AU4594900A (en) 2000-11-21
PT1178953E (pt) 2004-04-30
ATE255559T1 (de) 2003-12-15
BR0010465A (pt) 2002-02-13
DE60006954D1 (de) 2004-01-15
AP2001002321A0 (en) 2001-12-31
SK16052001A3 (sk) 2002-11-06
EA200101058A1 (ru) 2002-06-27
NO20015412D0 (no) 2001-11-06
HUP0201069A2 (hu) 2002-07-29
US6846953B1 (en) 2005-01-25
CA2373173A1 (en) 2000-11-16
MA26789A1 (fr) 2004-12-20
KR20010111594A (ko) 2001-12-19
IS6136A (is) 2001-10-30
HUP0201069A3 (en) 2002-11-28
DK1178953T3 (da) 2004-03-15
ES2208324T3 (es) 2004-06-16
CN1352631A (zh) 2002-06-05
IL146340A0 (en) 2002-07-25
EP1178953A1 (en) 2002-02-13
JP2002544186A (ja) 2002-12-24
OA11941A (en) 2006-04-12
DE60006954T2 (de) 2004-10-21
BG106072A (en) 2002-05-31
PL354356A1 (en) 2004-01-12
EP1178953B1 (en) 2003-12-03
WO2000068184A1 (en) 2000-11-16
NO20015412L (no) 2002-01-09
TR200103245T2 (tr) 2002-04-22
CZ20013924A3 (cs) 2002-04-17

Similar Documents

Publication Publication Date Title
MX9101557A (es) Acidos de hidroxialquilquinolina saturados como antagonistas de leucotrieno.
GEP20022676B (en) 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors
ES2162257T3 (es) N-aminoalquildibenzofurancarboxamidas como ligandos especificos del subtipo de receptor de la dopamina.
ATE233730T1 (de) Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende mittel und verfahren zu ihrer herstellung
DE60004066D1 (de) Benzofurylpiperazine: 5-ht2c serotoninrezeptor agonisten
SV1999000102A (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa. ref. pcs 9475 afae/bb.
GT200100160A (es) Derivados 4-fenil-piridina.
PT96085A (pt) Processo para a preparacao de ciclo-hexanois substituidos como agentes do sistema nervoso central
DE69901717D1 (de) Phosphohalohydrine, verfahren zu deren herstellung und verwendungen
ES2165360T3 (es) Cicloalquenos y cicloalcanos 1,3-sustituidos como agentes del sistema nervioso central.
DE69013601T2 (de) Heteroaryl Piperazine als antipsychotische Mittel.
AR029214A1 (es) Compuestos inhibidores de fosfodiesterasa - 4: 8 - arilquinolinas sustituidas, composiciones farmaceuticas, metodo de tratamiento que las utiliza
GT199800135A (es) 2 - aminopiridinas con sustituyentes alcoxi ramificados.
ES2084996T3 (es) Piperazinas sustituidas utiles como agentes para el sistema nervioso central.
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
ATE201676T1 (de) N-azacycloalkylalkyldibenzothiophencarboxamide: spezifische liganden für dopaminrezeptorsubtypen
YU44301A (sh) 5ht1 antagonisti za antidepresantnu terapiju
CR6500A (es) Amidas aromaticas
PE20001241A1 (es) Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores
PT96084A (pt) Processo para a preparacao de ciclo-hexenos substituidos utilizados como agentes do sistema nervoso central
BR0107823A (pt) Processo para a obtenção de ácido fórmico anidro ou substancialmente anidro, uso de uma carboxamida, e, aparelho para realizar um processo
RS50033B (sr) Derivati etansulfonil-piperidina
ES2062088T3 (es) Agente para la proteccion de plantas contra enfermedades.
ATE419238T1 (de) Arylsulfanyl und heteroarylsulfanyl-derivate zur behandlung von schmerz
DE69815380D1 (de) N,n'-bis (sulfonyl) hydrazine die als antineoplastische mittel nützlich sind

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)